Do hepatitis B virus-specific miRNAs and Argonaute2 play a role in the viral life cycle?
These results suggest that AGO2 and HBV-specific miRNAs might play a role in the HBV life cycle.
Regarding patients with neovascular age-related macular degeneration, increased understanding in its pathogenesis coupled with rapid development in instrumental technology and new/emerging medications greatly expands available treatment options. Despite these various therapeutic options, current treatment is mainly directed at achieving visual stabilisation. Restoration of vision with newer agents is limited and not possible in every patient. Thus, early recognition and treatment to arrest the progression of neovascular age-related macular degeneration is the preferred means of attaining the best visual outcome.